• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHB2100001 奥拉帕利片 olaparib Tablet Chemical Drugs Supplementary Application 2021-01-06 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-01-05 view
JXHL1900241 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2019-10-16 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2019-10-14 view
JXHL2000112 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2020-05-27 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2020-05-26 view
JYHB1801229 奥拉帕利片 olaparib Tablet Chemical Drugs(5.1) Supplementary Application 2018-10-17 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-11-26 view
JXHB2000049 奥拉帕利片 olaparib Tablet Chemical Drugs Supplementary Application 2020-11-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2020-11-20 view
JXHS1900038 奥拉帕利片 olaparib Tablet Chemical Drugs(5.1) Import Drug Application 2019-03-25 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2021-07-28 view
JXHL2100038 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2021-02-03 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-02-02 view
JXHL2000097 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2020-05-18 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2020-05-16 view
JXHL1800160 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2018-11-21 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2018-11-20 view
JXHL2000115 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2020-05-27 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2020-05-26 view
JXHL2000250 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2020-09-19 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2020-09-18 view
JXHL1900286 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2019-11-06 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2019-11-05 view
JXHL2000114 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2020-05-27 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2020-05-26 view
JXHL2000249 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2020-09-19 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2020-09-18 view
JXHL1900287 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2019-11-06 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2019-11-05 view
JXHL1800161 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2018-11-21 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2018-11-20 view
JXHB2100002 奥拉帕利片 olaparib Tablet Chemical Drugs Supplementary Application 2021-01-06 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2022-01-20 view
JXHL1900240 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2019-10-16 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2019-10-14 view
JXHL2000113 奥拉帕利片 olaparib Tablet Chemical Drugs(2.4) Import Drug Application 2020-05-27 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2020-05-26 view
JYHB1801230 奥拉帕利片 olaparib Tablet Chemical Drugs(5.1) Supplementary Application 2018-10-17 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-11-26 view